Regulatory Affairs Updates
Discover the latest news in Regulatory Affairs
New Q&A released on the gradual roll-out of EUDAMED
- Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager
Some key takeaways from the Q&A
The Q&A provides timelines and conditions for the activation and mandatory use of EUDAMED modules:
- Actor module,
- UDI/Device module,
- Notified bodies and certificates module,
- Market surveillance module,
- Post-market surveillance and Vigilance module,
- Clinical investigations/performance studies module.
Â
It also clarifies the timelines for their implementation and the conditions under which stakeholders can or must use these modules. To enhance understanding, the document includes examples of transition periods and offers detailed guidance on managing obligations during the roll-out phase.
What does it mean to you?
This publication provides critical information for stakeholders in the medical device and in vitro diagnostic industries.
By aligning with the phased roll-out, stakeholders can proactively manage their responsibilities and contribute to the broader goals of harmonization and enhanced oversight within the EU’s medical device and diagnostics framework.
Get in touch with our experts
Did you find this article interesting? Thanks for sharing it with your network:
Here you find all news related to Regulatory Affairs